What if the next blockbuster drug isn’t a molecule – but a frequency?

Electrome is leveraging AI to translate decades of bioelectric science into first-in-class treatments and novel combination therapies across high-burden disease areas.

Welcome to the Electrome

The Electrome Platform enables pioneering research and commercialization of therapies that harness the power of bioelectricity to transform both standalone and combination therapies.

360 Approach to Bioelectric Research, Development, and Commercialization

The Electrome Platform is designed to enable drug developers to rapidly identify, validate, and deliver targeted bioelectric signals that modulate ion channels and cellular voltage with extraordinary precision.

Scalable Bioelectric Therapeutics Platform

We are building the world’s first scalable platform for precision bioelectric therapies—non-invasive, programmable, and clinically validated to treat pain, inflammation, infection, and cancer.

Pain & Inflammation

Pain & Inflammation

Proven to reduce post-op pain and edema while lowering opioid use.

Learn more
Wound Healing

Wound Healing

Enhances tissue regeneration and healing outcomes across surgical and chronic wounds.

Learn more
Infectious Disease

Infectious Disease

Targets antibiotic-resistant bacteria through non-chemical, frequency-based disruption.

Learn more
Oncology

Oncology

Precise, non-invasive signal-based modulation of tumor microenvironments and growth cycles.

Learn more

Why start with Our Solutions?

Organize, oversee, and monitor interrelated tasks while having a real-time overview of the entire program’s scope.
Accelerate time to value

Accelerate time to value

Save time on software setup and deployment. Our solutions come with pre-built templates, configurations, and dashboards for immediate use.
Future-proof your R&D informatics

Future-proof your R&D informatics

Ensure that your R&D software remains aligned with your scientific goals. Our solutions can be customized as needed to accommodate the growth of your team.
Ensure successful R&D outcomes

Ensure successful R&D outcomes

Leverage the experience of thousands of successful implementations to ensure your team is building on a strong foundation for success, following industry best practices.
very tested

very tested

The solutions we offer have been tested and recognized by experts, so they can maximize the work of scientists and biotechnology.

Elecrome is powering a new era of Precision Medicine

The Electrome Platform enables pharmaceutical companies to identify programmable bioelectric signals that work in synergy with drugs to minimize side effects, unlock novel mechanisms, and enhance efficacy.

Minimize Side Effects

By stabilizing aberrant cellular voltage, bioelectric signals can reduce off-target effects, enabling lower doses and improved safety profiles.

Enable Novel Combinations

Electrome creates a new therapeutic class where waveform-based modulation works in tandem with pharmaceuticals—amplifying mechanisms of action and uncovering new therapeutic windows.

Enhance Drug Efficacy

Bioelectric modulation improves cellular uptake, prolongs therapeutic action, and primes biological systems for a stronger, more targeted response.

Scalable Bioelectric Therapeutics Platform

The world’s first scalable platform for precision bioelectric therapies, non-invasive, programmable, and clinically validated to treat pain, inflammation, infection, cancer, and beyond…

Pain & Inflammation

Pain & Inflammation

Alleviate pain, calm inflammation, and accelerate recovery with precision bioelectric signals—offering non-invasive relief while helping reduce reliance on opioids.

Learn more
Wound Healing

Wound Healing

Accelerate tissue regeneration and reduce scarring with bioelectric signals that promote angiogenesis, activate fibroblasts, and modulate immune response throughout the healing process.

Learn more
Infectious Disease

Infectious Disease

Combat antibiotic-resistant pathogens with precision electromagnetic signals that disrupt membranes, impair biofilms, and support immune defense.

Learn more
Oncology

Oncology

Target cancer cells with precision using electromagnetic signals proven to disrupt tumor growth, modulate immune response, and complement traditional oncology therapies.

Learn more
Neurology

Neurology

Activates neuroplastic repair pathways to support recovery from stroke, injury, neurodegenerative decline, and optimizing brain health.

Learn more
Longevity

Longevity

Stimulates cellular pathways tied to aging, improving tissue regeneration, metabolic balance, and resilience over time.

Learn more

The Electrome Platform

Why Work with Us?

We are creating an entirely new category in medicine—bioelectric therapeutics—grounded in decades of peer-reviewed science. Our first product is FDA-ready and set to generate revenue in year one.

Robust Scientific Evidence

Robust Scientific Evidence

Grounded in decades of peer-reviewed research and real-world clinical outcomes.

Platform Business Model

Platform Business Model

Scalable across multiple indications and device form factors—from consumer to clinical.

Accelerated Time to Market

Accelerated Time to Market

Stepwise FDA clearance strategy built on 510(k) and De Novo pathways with predicate devices in place.

Regulatory & IP Leadership

Regulatory & IP Leadership

Veteran team with clinical, science, FDA, CMS, and IP experience and track record of  commercial success.

Led by Proven Innovators

From academic medicine to federal health and commercialization, our team draws on decades of experience across institutions shaping modern healthcare.

HARVAR UNIVERSITY :
Baylor University :
Tufts University :
Stanford University :
Columbia University : Brand Short Description Type Here.
Mass General Hospital : Brand Short Description Type Here.
Mayo Clinic : Brand Short Description Type Here.
Brand Name : Brand Short Description Type Here.

Invest in the next frontier of Medicine